IPF AND PPF

Clinical trials for IPF AND PPF explained in plain language.

Never miss a new study

Get alerted when new IPF AND PPF trials appear

Sign up with your email to follow new studies for IPF AND PPF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug HRS-9813 aims to slow lung scarring in fibrosis patients

Disease control Recruiting now

This study tests a new drug called HRS-9813 in 270 adults with pulmonary fibrosis (IPF or PPF), a condition where lung tissue becomes scarred and breathing gets harder. The trial compares the drug to a placebo to see if it improves lung function and is safe. Participants take the…

Matched conditions: IPF AND PPF

Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

IPF AND PPF

Get alerted when new IPF AND PPF trials appear

New drug HRS-9813 aims to slow lung scarring in fibrosis patients